Advertisement
Screener

ANNEXON, INC. (ANNX) Form D

ANNEXON, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2020-07-16: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-06-30; Total offering amount $101,999,983.
  • 2018-12-19: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-12-07; Total offering amount $84,999,985.
  • 2011-08-22: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2011-08-16; Total offering amount $999,999.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2020-07-16Rule 506(b)Equity2020-06-30$101,999,983$101,999,983$017
2018-12-19Rule 506(b)Equity2018-12-07$84,999,985$44,999,994$39,999,99110
2011-08-22Rule 506Equity2011-08-16$999,999$999,999$01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
LIFECORE BIOMEDICAL, INC. DE (LFCR)United States$0.163B-8.50